Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DRD2 | P14416 | 15/20 | 0.79 |
| ▸ | DRD3 | P35462 | 14/20 | 0.60 |
| ▸ | HTR1A | P08908 | 2/20 | 0.54 |
| ▸ | ADRA2A | P08913 | 2/20 | 0.54 |
| ▸ | DRD4 | P21917 | 2/20 | 0.54 |
| ▸ | HTR2A | P28223 | 2/20 | 0.54 |
| ▸ | HTR2C | P28335 | 2/20 | 0.54 |
| ▸ | HTR7 | P34969 | 2/20 | 0.54 |
| ▸ | ADRA1A | P35348 | 2/20 | 0.54 |
| ▸ | HRH1 | P35367 | 2/20 | 0.54 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.54 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.54 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.54 |
| ▸ | DRD1 | P21728 | 1/20 | 0.54 |
| ▸ | DRD5 | P21918 | 1/20 | 0.54 |
| ▸ | HTR2B | P41595 | 1/20 | 0.54 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.54 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.54 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.54 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23330962 | 1.00 | DRD2 (0.79) | DRD2DRD3HTR1AADRA2ADRD4 | |
| SCHEMBL30579548 | 1.00 | DRD2 (0.79) | DRD2DRD3HTR1AADRA2ADRD4 | |
| SCHEMBL30065991 | 1.00 | DRD2 (0.79) | DRD2DRD3HTR1AADRA2ADRD4 | |
| SCHEMBL22302317 | 1.00 | DRD2 (0.79) | DRD2DRD3HTR1AADRA2ADRD4 | |
| Hydrochloric Acid SCHEMBL28474663 | 0.99 | DRD2 (0.77) | DRD2DRD3HTR1AADRA2ADRD4 | |
| SCHEMBL25106928 | 0.92 | DRD2 (0.68) | DRD2DRD3HTR1ADRD4HTR2A | |
| SCHEMBL20672353 | 0.88 | DRD2 (1.00) | DRD2DRD3HTR1AADRA2ADRD4 | |
| SCHEMBL2034152 | 0.88 | DRD2 (1.00) | DRD2DRD3HTR1AADRA2ADRD4 | |
| SCHEMBL1310960 | 0.88 | DRD2 (1.00) | DRD2DRD3HTR1AADRA2ADRD4 | |
| SCHEMBL30855316 | 0.88 | DRD2 (1.00) | DRD2DRD3HTR1AADRA2ADRD4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117242058-A | Salt containing piperazine polycyclic derivative and crystal form, and preparation method and application thereof | 上海翰森生物医药科技有限公司 | 2023-12-15 | — | — | CN | disclosed |
| CN-111770754-B | Polycyclic derivative regulator, preparation method and application thereof | 江苏豪森药业集团有限公司 | 2023-09-19 | — | — | CN | disclosed |
| US-20230076435-A1 | MODIFIER OF FOUR-MEMBERED RING DERIVATIVE, PREPARATION METHOD AND APPLICATION THEREOF | SHANGHAI HANSOH BIOMEDICAL CO., LTD. (CN) | 2023-03-09 | — | — | US | disclosed |
| CN-115246801-A | Free base crystal form containing piperazine polycyclic derivative and preparation method and application thereof | 上海翰森生物医药科技有限公司 | 2022-10-28 | — | — | CN | disclosed |
| EP-4053110-A1 | MODIFIER OF FOUR-MEMBERED RING DERIVATIVE, PREPARATION METHOD AND APPLICATION THEREOF | Shanghai Hansoh Biomedical Co., Ltd. (CN) | 2022-09-07 | — | — | EP | disclosed |
| CN-113056454-A | Quadricyclic derivative regulator, preparation method and application thereof | 上海翰森生物医药科技有限公司 | 2021-06-29 | — | — | CN | disclosed |
| WO-2021083246-A1 | MODIFIER OF FOUR-MEMBERED RING DERIVATIVE, PREPARATION METHOD AND APPLICATION THEREOF | 上海翰森生物医药科技有限公司 | 2021-05-06 | — | — | WO | disclosed |
| CN-111770754-A | Polycyclic derivative regulator, preparation method and application thereof | 江苏豪森药业集团有限公司 | 2020-10-13 | — | — | CN | disclosed |
| WO-2020156312-A1 | POLYCYCLIC DERIVATIVE MODULATOR, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF | 江苏豪森药业集团有限公司 | 2020-08-06 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230076435-A1 | MODIFIER OF FOUR-MEMBERED RING DERIVATIVE, PREPARATION METHOD AND APPLICATION THEREOF | GRM4, GRM5, GRIA4 | DRD2 343/4885DRD3 367/4885HTR1A 75/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.